Papers
2
Total Citations
66
H-Index
2
About
Shuiqing Ma is a leading clinical researcher in gynecologic oncology, with a focused expertise in the surgical management of early-stage cervical cancer. Her work is at the forefront of a critical debate in the field: the balance between the benefits of minimally invasive surgery (MIS) and the imperative for optimal oncologic outcomes. Dr. Ma’s major contribution is the design and leadership of pivotal, large-scale randomized controlled trials in China that directly challenge and refine global surgical standards. Her most cited work, a 2019 phase III trial protocol (56 citations), rigorously investigates the efficacy of different surgical approaches—including MIS versus open surgery—for early-stage cervical cancer, a study prompted by the controversial findings of the international LACC trial. She further extends this inquiry into fertility-sparing surgery with a 2020 protocol comparing minimally invasive versus open radical trachelectomy. By spearheading these high-impact, multicenter trials, Dr. Ma is generating the high-level evidence necessary to guide surgeons in selecting the safest, most effective technique, ultimately shaping clinical practice and improving survival outcomes for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2